NLS Pharmaceutics Ltd. Warrant (NLSPW) Total Assets by Year
NLS Pharmaceutics Ltd. Warrant closed fiscal year 2025 with $11.4M in total assets, $4.2M in total liabilities and $7.3M in shareholder equity. This represents an increase of 1167.4% from the prior fiscal year. The table below carries 8 fiscal years, from 2018 to 2025, and the quarters NLS Pharmaceutics Ltd. Warrant has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
NLSPW Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2510-K | FY2410-K | FY2310-K | FY22 | FY21 | FY20 | FY19 | FY18 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $11.4M+1167.4% | $903K-51.1% | $1.8M-80.1% | $9.3M+60.9% | $5.8M+375.8% | $1.2M+74.0% | $696K | N/A |
| Total Liabilities | $4.2M-52.9% | $8.9M+192.4% | $3.0M-66.8% | $9.2M+75.5% | $5.2M-48.8% | $10.2M+48.5% | $6.9M | N/A |
| Total Equity | $7.3M+190.7% | -$8.0M-568.0% | -$1.2M-1178.4% | $111K-79.5% | $542K+106.0% | -$9.0M-45.6% | -$6.2M+30.0% | -$8.8M |
NLSPW Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q4'2510-K | Q2'2510-Q | Q4'2410-K | Q2'24 | Q4'23 | Q2'23 | Q4'22 | Q2'22 | Q4'21 | Q2'21 | Q4'20 | Q4'19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $11.4M+1167.4% | $4.3M+263.5% | $903K-51.1% | $1.2M-47.4% | $1.8M-80.1% | $2.3M+10.3% | $9.3M+60.9% | $2.1M-75.1% | $5.8M+375.8% | $8.3M | $1.2M+74.0% | $696K |
| Total Liabilities | $4.2M-52.9% | $1.5M-86.1% | $8.9M+192.4% | $10.5M+59.6% | $3.0M-66.8% | $6.6M+7.5% | $9.2M+75.5% | $6.1M+51.7% | $5.2M-48.8% | $4.0M | $10.2M+48.5% | $6.9M |
| Total Equity | $7.3M+190.7% | $2.9M+131.1% | -$8.0M-568.0% | -$9.3M-116.2% | -$1.2M-1178.4% | -$4.3M-6.1% | $111K-79.5% | -$4.0M-195.1% | $542K+106.0% | $4.2M | -$9.0M-45.6% | -$6.2M |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More NLS Pharmaceutics Ltd. Warrant financials
Frequently Asked Questions
What was NLS Pharmaceutics Ltd. Warrant's total assets in fiscal year 2025?
NLS Pharmaceutics Ltd. Warrant closed fiscal year 2025 with $11.4M in total assets, $4.2M in total liabilities and $7.3M in shareholder equity.
How fast is NLS Pharmaceutics Ltd. Warrant's total assets growing?
NLS Pharmaceutics Ltd. Warrant (NLSPW) total assets rose by 1167.4% year over year, from $903K to $11.4M in fiscal year 2025.
What was NLS Pharmaceutics Ltd. Warrant's total assets in the most recent quarter?
NLS Pharmaceutics Ltd. Warrant (NLSPW) reported $11.4M in total assets in Q4 2025. This represents an increase of 1167.4% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what NLS Pharmaceutics Ltd. Warrant (NLSPW) reported on that line in every period on record.